CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
MIGIX
Price
$19.37
Change
-$0.53 (-2.66%)
Updated
Jul 13 closing price
Net Assets
56.3M
Interact to see
Advertisement

CNPAX vs MIGIX

CNPAX vs MIGIX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MIGIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and MIGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. MIGIX (56.3M). CNPAX pays higher dividends than MIGIX: CNPAX (0.95) vs MIGIX (0.00). CNPAX was incepted earlier than MIGIX: CNPAX (24 years) vs MIGIX (16 years). MIGIX (1.53) is less costly to investors than CNPAX (0.74). MIGIX is a more actively managed with annual turnover of: 66.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than MIGIX: CNPAX (250) vs MIGIX (1000000). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. MIGIX (1.43). CNPAX return over 5 years is better than : 13.82 vs. MIGIX (-40.78).
CNPAXMIGIXCNPAX / MIGIX
Total Expense Ratio0.741.0074%
Annual Report Gross Expense Ratio0.741.5348%
Fund Existence24 years16 years-
Gain YTD5.3250.2012,644%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets170B56.3M301,954%
Annual Yield % from dividends0.950.00-
Returns for 1 year7.371.43516%
Returns for 3 years34.1784.6640%
Returns for 5 years13.82-40.78-34%
Returns for 10 years115.9166.13175%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6